2012-09-18 08:08:30 - New Pharmaceuticals market report from Global Markets Direct: "Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2012"

Global Markets Direct's, 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2012', provides an overview of the Chronic Obstructive Pulmonary Disease (COPD) therapeutic pipeline. This report provides information on the therapeutic development for Chronic Obstructive Pulmonary Disease (COPD), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chronic Obstructive Pulmonary Disease (COPD). 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
-

www.fastmr.com/prod/463825_chronic_obstructive_pulmonary_disease ..


Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Chronic Obstructive Pulmonary Disease (COPD).
* A review of the Chronic Obstructive Pulmonary Disease (COPD) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Chronic Obstructive Pulmonary Disease (COPD) pipeline on the basis of route of administration and molecule type.
* Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Chronic Obstructive Pulmonary Disease (COPD).
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Chronic Obstructive Pulmonary Disease (COPD) pipeline depth and focus of Chronic Obstructive Pulmonary Disease (COPD) therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Keywords

Chronic Obstructive Pulmonary Disease (COPD) Therapeutic Products under Development, Key Players in Chronic Obstructive Pulmonary Disease (COPD) Therapeutics, Chronic Obstructive Pulmonary Disease (COPD) Pipeline Overview, Chronic Obstructive Pulmonary Disease (COPD) Pipeline, Chronic Obstructive Pulmonary Disease (COPD) Pipeline Assessment

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Chronic Obstructive Pulmonary Disease (COPD) Overview
Therapeutics Development
An Overview of Pipeline Products for Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease (COPD) Therapeutics under Development by Companies
Chronic Obstructive Pulmonary Disease (COPD) Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Chronic Obstructive Pulmonary Disease (COPD) Therapeutics - Products under Development by Companies
Chronic Obstructive Pulmonary Disease (COPD) Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Development
Johnson & Johnson
Boehringer Ingelheim GmbH
Kyowa Hakko Kirin Co., Ltd.
Osiris Therapeutics, Inc.
Amgen Inc.
AstraZeneca PLC
GlaxoSmithKline plc
MedImmune LLC
Daiichi Sankyo Company, Ltd
Merck & Co., Inc.
Pearl Therapeutics, Inc.
Nycomed International Management GmbH
Rib-X Pharmaceuticals, Inc.
Novartis AG
REVOTAR Biopharmaceuticals AG
Aquinox Pharmaceuticals Inc.
Aridis Pharmaceuticals LLC
ProtAffin Biotechnologie AG
Funxional Therapeutics Ltd
Promedior, Inc.
Pulmatrix, Inc.
MSM Protein Technologies, Inc.
Reata Pharmaceuticals, Inc.
AIM Therapeutics Inc.
BioMarck Pharmaceuticals, Ltd.
Vantia Therapeutics
Inverseon, Inc.
Polyphor Ltd.
NanoBio Corporation
Sparsha Pharma International Pvt. Ltd.
iNova Pharmaceuticals (Australia) Pty Limited
Adamis Pharmaceuticals Corporation
SuppreMol GmbH
Stelic Institute & Co.
Pierre Fabre Medicament
Aphoenix, Inc.
MicroDose Therapeutx, Inc.
Elevation Pharmaceuticals, Inc.
Beech Tree Labs, Inc.
N30 Pharmaceuticals
Errant Gene Therapeutics, LLC
Stempeutics Research Private Limited
Clarassance, Inc.
Chronic Obstructive Pulmonary Disease (COPD) - Therapeutics Assessment
Assessment by Monotherapy Products

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=463825&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.